NIQ CLO awarded 39,508 restricted share units

NIQ Global Intelligence plc Chief Legal Officer John W. Blenke reported an equity compensation grant in the form of restricted share units.

Rhea-AI Filing Summary

NIQ Global Intelligence plc Chief Legal Officer John W. Blenke reported an equity compensation grant in the form of restricted share units. He acquired 39,508 RSUs, each representing a contingent right to receive one ordinary share of NIQ at no cash cost per share.

The RSUs vest in 33% increments on each of the first, second, and third anniversaries of the vesting commencement date of February 18, 2026. Following this award, Blenke directly owns 104,251 ordinary shares, and an additional 156,310 ordinary shares are held indirectly by AI PAVE (Luxembourg) Management & Cy S.C.Sp. for his benefit, subject to vesting under the applicable award agreement.

Insider Trade Summary

Grant/Award: 39,508 shares

Grant/Award 2 txns

Insider Blenke John W

Role Chief Legal Officer

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares	39,508	$0.00	$0.00
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Ordinary Shares — 104,251 shares (Direct); Ordinary Shares — 156,310 shares (Indirect, See Footnote)

Footnotes (2)

1. F1. Grant of 39,508 restricted share units ("RSUs"). Each RSU represents a contingent right to receive one ordinary share of the Issuer. The RSUs vest in 33% increments on the three anniversaries of the vesting commencement date of February 18, 2026.
2. F2. Represents shares held by AI PAVE (Luxembourg) Management & Cy S.C.Sp. for the benefit of the reporting person subject to vesting under the applicable award agreement.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did NIQ Chief Legal Officer John W. Blenke report?

John W. Blenke reported an equity award of 39,508 restricted share units of NIQ. Each RSU represents a contingent right to receive one ordinary share, reflecting non-cash executive compensation tied to future service and vesting conditions.

At what price were the NIQ restricted share units granted to John W. Blenke?

The 39,508 restricted share units were granted at a reported price of $0.00 per share. This indicates a compensation award rather than an open-market purchase, aligning with typical stock-based incentives for senior executives.

How do John W. Blenke’s NIQ RSUs vest over time?

The 39,508 NIQ RSUs vest in 33% increments on each of the three anniversaries of the vesting commencement date of February 18, 2026. This three-year schedule encourages ongoing service and long-term alignment with shareholders.

How many NIQ shares does John W. Blenke hold directly after this Form 4?

After the reported award, John W. Blenke directly owns 104,251 NIQ ordinary shares. This direct holding figure comes from the Form 4 line showing total shares following the grant of 39,508 restricted share units.

What are the indirect NIQ share holdings reported for John W. Blenke?

The filing shows 156,310 NIQ ordinary shares held indirectly by AI PAVE (Luxembourg) Management & Cy S.C.Sp. for Blenke’s benefit. These shares are subject to vesting under an applicable award agreement, as described in the footnote.

Does the NIQ Form 4 show a buy or sell of shares by John W. Blenke?

The Form 4 reports an acquisition through a grant or award of 39,508 restricted share units, coded as a grant-type transaction. It does not report any open-market buy or sell transactions in NIQ shares by Blenke.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/20/2026 - 04:06 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Blenke John W

(Last) (First) (Middle)

C/O NIQ GLOBAL INTELLIGENCE PLC.

200 WEST JACKSON BOULEVARD

(Street)

CHICAGO IL 60606

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NIQ Global Intelligence plc [ NIQ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/18/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	02/18/2026		A(1)		39,508	A	$0	104,251	D
Ordinary Shares								156,310	I	See Footnote(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of 39,508 restricted share units ("RSUs"). Each RSU represents a contingent right to receive one ordinary share of the Issuer. The RSUs vest in 33% increments on the three anniversaries of the vesting commencement date of February 18, 2026.

2. Represents shares held by AI PAVE (Luxembourg) Management & Cy S.C.Sp. for the benefit of the reporting person subject to vesting under the applicable award agreement.

Remarks:

	/s/John Blenke	02/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.